The MarketWatch News Department was not involved in the creation of this content. THE WOODLANDS, Texas, Dec. 2, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development ...
The addition of the 50-liter single-use bioreactor significantly expands Cellipont's cGMP-compliant capacity, enabling clients to seamlessly transition from early development to large-scale, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback